Patient and provider costs of the new BPaL regimen for drugresistant tuberculosis treatment in South Africa A costeffectiveness analysis

dc.article.end-page19en
dc.article.start-page1en
dc.citation.doi10.1371/JOURNAL.PONE.0309034en
dc.contributor.authorDenise Evansen
dc.contributor.authorKamban Hirasenen
dc.contributor.authorClive Ramushuen
dc.contributor.authorLawrence Longen
dc.contributor.authorE Sinanovicen
dc.contributor.authorFrancesca CONRADIEen
dc.contributor.authorPauline Howellen
dc.contributor.authorX Padanilamen
dc.contributor.authorH Ferreiraen
dc.contributor.authorEbrahim Variavaen
dc.contributor.authorShakira Rajaramen
dc.contributor.authorE et alen
dc.date.accessioned2025-04-12T10:43:47Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1932-6203en
dc.identifier.urihttps://hdl.handle.net/10539/44732
dc.journal.titlePatient and provider costs of the new BPaL regimen for drugresistant tuberculosis treatment in South Africa A costeffectiveness analysisen
dc.journal.volume19en
dc.titlePatient and provider costs of the new BPaL regimen for drugresistant tuberculosis treatment in South Africa A costeffectiveness analysisen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
477.19 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client